Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice

被引:39
作者
Ko, J
Gendron-Fitzpatrick, A
Ficht, TA
Splitter, GA
机构
[1] Univ Wisconsin, Cellular & Mol Immunol Lab, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Res Anim Resource Ctr, Madison, WI 53705 USA
[3] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA
[4] Texas A&M Univ, Texas Agr Expt Stn, College Stn, TX 77843 USA
关键词
D O I
10.1128/IAI.70.12.7004-7012.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interferon regulatory factor 1-deficient (IRF-1(-/-)) mice infected with virulent Brucella abortus 2308 at 5 x 10(5) CFU developed acute hepatitis similar to many natural hosts but, unlike natural hosts, IRF-1(-/-) mice were unable to resolve infection and died. In contrast, IRF-1(-/-) mice survived when infected at 5 x 10(5) CFU with several attenuated Brucella strains (S19, RB51, cbp, and cyd). The survival of infected IRF-1(-/-) mice is likely a function of the level of virulence of each Brucella strain and the extent of retained immunity. Further, these findings suggest that adaptive immunity may be important to the survival of IRF-1(-/-) mice since attenuated Brucella strains can protect IRF-1(-/-) mice against lethal challenge with virulent Brucella. Using the IRF-1(-/-) mouse model, the following set of criteria were identified to define Brucella virulence: (i) the day of death for 50% of mice infected with 5 x 10(5) CFU of Brucella, (ii) the extent of liver toxicity, and (iii) the minimum immunizing dose of Brucella to protect against challenge with virulent S2308. Thus, IRF-1(-/-) mice are important to determining the level of Brucella virulence, to evaluating Brucella mutants for attenuation, and to investigating adaptive immunity in brucellosis.
引用
收藏
页码:7004 / 7012
页数:9
相关论文
共 31 条
[1]  
Alcalá L, 1999, AM J MED, V107, P300, DOI 10.1016/S0002-9343(99)00089-3
[2]  
Baldwin C L, 1994, Immunol Ser, V60, P363
[3]   BRUCELLA-SUIS S2, BRUCELLA-MELITENSIS REV-1 AND BRUCELLA-ABORTUS S19 LIVING VACCINES - RESIDUAL VIRULENCE AND IMMUNITY INDUCED AGAINST 3 BRUCELLA SPECIES CHALLENGE STRAINS IN MICE [J].
BOSSERAY, N ;
PLOMMET, M .
VACCINE, 1990, 8 (05) :462-468
[4]  
BRINLEYMORGAN WJ, 1990, TOPLEY WILSONS PRINC, P547
[5]   ASCITES AS THE 1ST MANIFESTATION OF BRUCELLA GRANULOMATOUS HEPATITIS [J].
CABALLERIA, E ;
MASSO, RM ;
ARAGO, JV ;
SANCHIS, A .
JOURNAL OF HEPATOLOGY, 1992, 15 (03) :415-416
[6]  
CHEVILLE NF, 1995, LAB INVEST, V73, P96
[7]  
Corbel M. J., 1990, Topley & Wilson's Principles of bacteriology, virology and immunity. Volume 2. Systematic bacteriology., P339
[8]  
CRAWFORD JM, 1999, PATHOLOGIC BASIS DIS, P845
[9]   Interruption of the cydB focus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection [J].
Endley, S ;
McMurray, D ;
Ficht, TA .
JOURNAL OF BACTERIOLOGY, 2001, 183 (08) :2454-2462
[10]   Brucella abortus genes identified following constitutive growth and macrophage infection [J].
Eskra, L ;
Canavessi, A ;
Carey, M ;
Splitter, G .
INFECTION AND IMMUNITY, 2001, 69 (12) :7736-7742